authors
- Gauvreau, Gail
- Boulet, Louis Philippe
- Cockcroft, Donald W
- Baatjes, Adrian
- Cote, Johanne
- Deschesnes, Francine
- Davis, Beth
- Strinich, Tara
- Howie, Karen
- Duong, Mylinh
- Watson, Richard M
- Renzi, Paolo M
- O'Byrne, Paul
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 1, 2008
has subject area
- 11 Medical and Health Sciences (FoR)
- Administration, Inhalation (MeSH)
- Adult (MeSH)
- Allergens (MeSH)
- Asthma (MeSH)
- Cross-Over Studies (MeSH)
- Double-Blind Method (MeSH)
- Drug Combinations (MeSH)
- Female (MeSH)
- Flow Cytometry (MeSH)
- Follow-Up Studies (MeSH)
- Forced Expiratory Volume (MeSH)
- Gene Expression (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Nebulizers and Vaporizers (MeSH)
- Oligonucleotides, Antisense (MeSH)
- Phosphorothioate Oligonucleotides (MeSH)
- Pulmonary Eosinophilia (MeSH)
- RNA, Messenger (MeSH)
- Receptors, CCR3 (MeSH)
- Receptors, Cytokine (MeSH)
- Respiratory System (Science Metrix)
- Reverse Transcriptase Polymerase Chain Reaction (MeSH)
- Sputum (MeSH)
- Treatment Outcome (MeSH)